Evidence that α2‐antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation
- 18 August 2008
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 6 (9) , 1565-1570
- https://doi.org/10.1111/j.1538-7836.2008.03056.x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The effect of a single nucleotide polymorphism on human α2-antiplasmin activityBlood, 2007
- Plasma fibrinogen γ′ chain content in the thrombotic microangiopathy syndromeJournal of Thrombosis and Haemostasis, 2006
- Cross-linking of Plasminogen Activator Inhibitor 2 and α2-Antiplasmin to Fibrin(ogen)Published by Elsevier ,2000
- Evidence for Intramolecular Cross-Linked Aα·γ Chain Heterodimers in Plasma FibrinogenBiochemistry, 1996
- Different NH2-Terminal Form with 12 Additional Residues of α2-Plasmin Inhibitor from Human Plasma and Culture Media of HEP G2 CellsBiochemical and Biophysical Research Communications, 1994
- Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.Journal of Clinical Investigation, 1993
- COVALENT STRUCTURE OF FIBRINOGENAnnals of the New York Academy of Sciences, 1983
- Reversible cross-linking of α2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- BIOCHEMICAL AND CHROMATOGRAPHIC STUDIES OF CERTAIN ACTIVITIES ASSOCIATED WITH HUMAN FIBRINOGEN PREPARATIONS*Journal of Clinical Investigation, 1963